India is set to become one of the earliest markets for Novo Nordisk's breakthrough once-weekly insulin,The Danish drug maker is preparing to launch Awiqli after securing regulatory approval.
Marksans Pharma has taken another step to expand its Europe presence by signing a deal to acquire Germany-based ABCnow GmbH.
AI healthcare growth is turning India into one of the world's biggest centers for medical technology innovation.
Researchers have developed a new one injection treatment that could reduce the need for osteoarthritis surgery in the future.
The Pharma Industry witnessed another eventful week, with developments across regulation, innovation, manufacturing, and public health.
The government sets new regulatory rules on drug launches, that relieves the hurdles for Indian manufacturers in obtaining regulatory approvals for supply delays. This in turn, aims to improve the quick market entry of drugs and improve sales
India may need to rethink its India drug rules before making changes that could impact the country's position as a global leader in affordable medicines.
Good health is not built through quick fixes. It grows from small Health Habits that people follow every day. Most doctors say the basics beat any supplement or diet trend.
A monthly recap on major events in indian pharmacuetical industry, which saw numerous policy reforms, innovation, drug approvals, and disease control methods
India has earned global recognition for its India pharma industry, but the next phase of growth could depend on a major shift.